Product Description
Ginkgo Biloba P.E.Flavone 24% Lactone 6%HPLC.Water Soluble Ginkgo Biloba P.E.Flavonoids 24% Lactone 6%HPLC. Grade available:
1.injection grade.
2.drink grade.

Botanical Source:Ginkgo Biloba leaves.[Synonyms and Common names]: Maidenhair tree, Kew tree, Fossil tree,Ginkgo, Maidenhair-Tree, Bai Guo. aidenhair Tree Leaves(English), Ginkgo biloba L.(Latin),L''extrait de Ginkgoac¨|es solubilis¨|(French),echter Ginkgobaum(Germany)
........Common Names&Synonyms:Ginkgo Biloba Leaf PE,Ginkgo Biloba Leaves PE,Ginkgo Biloba Leaves Pwd,Ginkgo Extract,Ginkgo Biloba Standardized Extract,Ginkgo Leaf pe,Water soluble Ginkgo Biloba Extract.


Ginkgo standardized extracts have been widely used in Europe for a wide variety of clinical conditions associated with age-related physical and mental deterioration. These include:

1) Alzheimer''s Disease / age-related dementia: Ginkgo extracts appear to be capable of stabilizing and, in some cases, improving the cognitive performance of patients with schizophrenia. Based on a quantitative analysis of the literature there is a small but significant effect of 3 to 6 month treatment with 120 to 240 mg of Gbe on objective measures of cognitive function in Alzheimer''s Disease ( Oken, Oregon Health Sciences University, 1998 ). The last publication ( Le Bars, Memory Centers of America, New York, Jan 2002 ) indicated that " a treatment effect favorable to EGb could be observed with respect to cognitive performance and social functioning regardless of the stage of dementia, whether mild or moderately severe. However, the relative changes from baseline measured at endpoint depended heavily on the severity at baseline. Improvement was observed in the group of patients with very mild to mild cognitive impairment, while in more severe dementia, the mean EGb effect should be considered more in terms of stabilization or slowing down of worsening, as compared to the greater deterioration observed with placebo". Further research in the area will need to determine if there are functional improvements and to determine the best dosage. Additional research will be needed to define which ingredients in the ginkgo extract are producing its effect in individuals with AD. A recent study makes clear that EGb treatment may enhance the effectiveness of antipsychotic drugs and reduce their extrapyramidal side effects( Zhang, Yale University School of Medicine, 2001 ).

2) Cardiovascular Disease: Treatment with Ginkgo biloba extract lowers fibrinogen levels and decreases plasma viscosity ( EGb can limit oxidative stress )

3) Cerebral vascular insufficiency and impaired cerebral performance: Administration of EGb has been shown to improve a variety of conditions associated with cognitive functions, particularly for memory loss, attention, alertness, vigilance, reaction times and depressive mood. A recent australian study indicates significant improvements in speed of information processing working memory and executive processing attributable to the EGb ( Stough C, Swinburne University of Technology, Melbourne, 2001 ).

Other therapeutic applications include:

1) Congestive symptoms of premenstrual syndrome: Ginkgo extract was effective for the treatment of the congestive (particularly breast symptoms) and neuropsychological symptoms of PMS.

2) Intermittent Claudication: A recent meta-analysis ( Pittler, University of Exeter, 2000 ) found a significant difference in the increase in pain-free walking distance in favor of Ginkgo biloba (weighted mean difference: 34 meters ). In studies using similar methodological features (ergometer speed: 3 km/h, inclination: 12%) this difference was 33 meters in favor of Ginkgo biloba.

3) Vertigo / Equilibrium Disorder / Prevention of altitude sickness.

4) Tinnitus (ringing in the ear). An overview ( Holstein, Karlsruhe, 2001 ) of results of 19 clinical trials shows a statistically significant superiority of treatment with the Gbe 761 as compared with placebo or reference drugs applied of periods of 1 to 3 months. " Therapeutic success was not directly correlated with either the genesis or the duration of tinnitus. However, investigations of prognostic factors revealed that short-standing disorders have a better prognosis, so that better results can be expected from early-onset treatment."

5) Liver Fibrosis: Ginkgo biloba was shown to be effective in arresting the development of liver fibrosis associated with chronic hepatitis B.

6) Macular degeneration: In spite of the small population sample, a statistically significant improvement in long distance visual acuity was observed in patients with macular degeneration.

Product Specification/Models
Specifications and Supplying Conditions:

Description: 100% Water Soluble Ginkgo Biloba Extracts.
Plant Part Used: Ginkgo Biloba Leaf
Content Standardized: Flavone glycosides>24%(Result NLT27%);Terpene lactones >6%HPLC(Result 7%);Ginkgo Acid <1ppm(Result Negative)
Serie Code: S-017
Expiration Date: 18~24Months in Good Condition
Storage Stock: Bulk in Stock
Pricing Terms: C&F;CIF;DDU;DDP.
Delivery Arrange: Soonest on the Day Confirmed

Appearance Showing: Golden Fine Powder
Extracts State: Fine Crystal Powder
Mesh Size: 100% Pass 80 Mesh Screen
Color: Golden
Odor and Smell: Charateristics Aromatic
Taste Sense: Flavour with Characteristics,Bitter Sour.
Bulk Density: 0.52g/ml.



Reference Link: Click for more Details

Payment
tt

Delivery
soon

Origin
cn

Minimum Order
1kilos

Packaging
25kilo drums

Inspection
HPLC

Samples
Free

Sample Price
US$0